Suchergebnisse - "DPT0O3T46P"

PubPharm (17)

1

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination

enthalten in: Journal for immunotherapy of cancer | 2024

von Watson, R. | Ye, W. | Taylor, C. | +16

2

An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic

enthalten in: Immunotherapy | 2023

von Moffat, G. | Hanna, L. | Hopman, W. | +2

3

Pembrolizumab-related pneumonitis in a patient with COVID-19 infection

enthalten in: Singapore medical journal | 2023

von Ponnalagu, V. | Kwan, E. | Sadasiv, M. | +2

4

Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer : before and during the COVID-19 pandemic

enthalten in: Journal of cancer research and clinical oncology | 2023

von Ksienski, D. | Gupta, S. | Truong, P. | +10

5

Case report : Electrocardiographic changes in pembrolizumab-induced fatal myocarditis

enthalten in: Frontiers in immunology | 2023

von Nishiyama, K. | Morikawa, K. | Shinozaki, Y. | +8

6

First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin

enthalten in: European urology | 2022

von Meghani, K. | Cooley, L. | Choy, B. | +6

CommentIn: Eur Urol. 2022 Dec;82(6):611-612. - PMID 36153248

7

Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation

enthalten in: JAMA oncology | 2022

von Strohbehn, G. | Holleman, R. | Burns, J. | +5

8

Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO) : A randomized proof-of-concept phase II study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Sánchez-Conde, M. | Vizcarra, P. | Pérez-García, J. | +10

9

Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716) : a randomised, double-blind, phase 3 trial

enthalten in: Lancet (London, England) | 2022

von Luke, J. | Rutkowski, P. | Queirolo, P. | +26

CommentIn: Nat Rev Clin Oncol. 2022 Jun;19(6):359. - PMID 35440772

10

Neoadjuvant PD-1 Inhibitors and Chemotherapy for Locally Advanced NSCLC : A Retrospective Study

enthalten in: The Annals of thoracic surgery | 2022

von Chen, T. | Ning, J. | Campisi, A. | +8